Does Robinhood Crypto Present a Threat to Coinbase?
Robinhood may be super popular with millennial traders, but it won’t overthrow Coinbase in the crypto world.
That’s according to Adam Draper, founder and managing director at start-up accelerator Boost VC. Also a Coinbase investor, he says he doesn’t view the companies as competing platforms.
“If you think long-term, they’re both looking at [trading digital coins] from completely different sides,” he told Cheddar. “Robinhood is coming at it from an asset management side, where Coinbase is coming at it from a crypto platform side.”
Robinhood Crypto went live in five states Thursday, offering zero-fee trading and promising a roll out more broadly in the coming months.
While some argue the no-commission strategy could take share away from Coinbase, Draper says the platform has a different target audience.
“With Coinbase Custody, they’re rolling out to institutional investors,” he said. “Robinhood is much more focused on the consumer, millennial generation.”
For the full interview, [click here](https://cheddar.com/videos/what-robinhoods-crypto-trading-means-for-coinbase).
At least 7 million customers have been impacted by a data breach on the investing app Robinhood. The specific information that was leaked varied by each customer, but Robinhood stated that hackers did not access social security numbers or banking information.
Paulina Likos, Investing Reporter at US News & World report, joined Wake Up With Cheddar to break down how the U.S. reopening its borders to foreign travelers might provide a big boost to the hard-hit travel and tourism industry.
The world hit a grim milestone on Monday, with COVID-19 cases surpassing a quarter of a billion worldwide. As cases increase, the fight to beat the virus continues as well, with a number of medical breakthroughs coming out over the last few months in the form of pills from Pfizer and Merck. Regeneron is now the latest company to join the fight, recently releasing new data on a covid antibody cocktail. Professor Peter Pitts, former FDA Associate Commissioner and the founder of the Center for Medicine in the Public Interest breaks down the differences between the 3 treatments and why vaccines are still among the fire line of defense.
Doug Astrop, managing partner at Exponential Investment Partners, joined Cheddar to discuss Peloton's precipitous price drop, and whether the company can recover as the at-home workout trend tapers off. "They've lowered the prices on their equipment to try to attract a bigger audience because ultimately they're sort of headed to this Apple ecosystem model where they can monetize a loyal customer base," he said. Astrop noted that he believes there is a reality where the in-person gym experience and Peloton's at-home programs can co-exist.
Bill Stone, Chief Investment Officer at Glenview Trust Company, joined Wake Up With Cheddar to break down markets headlines ahead of the start of the trading week.
Jill and Carlo discuss the scenes of joy at American airports as borders reopen, another tool in the Covid toolbox, the latest in the Astroworld crowd crush tragedy and more.
Next week will see several different events that will likely weigh on the markets. Cheddar News' Closing Bell dives in, from the continuation of third-quarter earnings season to Rivian's IPO and a 're-IPO' from Hertz, along with more inflation data.
